Costs and management of patients with hemophilia A in France: the Hemraude studyEUROPEAN JOURNAL OF HEALTH ECONOMICSIF32021-07-087PREAI
IDENTIFICATION AND ESTIMATION OF THE PREVALENCE OF ACUTE SEVERE ASTHMA IN FRANCE USING THE EGB CLAIM DATABASEVALUE IN HEALTHIF62018-10-010OAAI
HEALTHCARE COST OF PATIENTS PRESENTING WITH PERIPHERAL ARTERY DISEASE (PAD): AN ANALYSIS USING A CLAIMS DATABASE IN FRANCEVALUE IN HEALTHIF62016-11-010OAAI
CARDIOVASCULAR EVENTS OF PATIENTS PRESENTING WITH PERIPHERAL ARTERY DISEASE (PAD): AN EPIDEMIOLOGICAL ANALYSIS USING A CLAIMS DATABASE IN FRANCEVALUE IN HEALTHIF62016-11-010OAAI
PREVALENCE, COMORBIDITIES AND BURDEN OF SEVERE SPONDYLOARTHRITIS IN FRANCE: ANALYSIS OF A NATIONAL PUBLIC HEALTH INSURANCE DATABASE IN 2012 IN FRANCEVALUE IN HEALTHIF62015-11-012OAAI
INCREASED COSTS DUE TO MYOCARDIAL INFARCTION (MI) IN FRANCE: AN OBSERVATIONAL ANALYSIS USING A CLAIMS DATABASEVALUE IN HEALTHIF62015-11-013OAAI
INCIDENCE OF CARDIOVASCULAR EVENTS FOLLOWING MYOCARDIAL INFARCTION IN FRANCE: AN OBSERVATIONAL ANALYSIS USING A CLAIMS DATABASEVALUE IN HEALTHIF62015-11-010OAAI
PREVALENCE DETERMINATION OF SEVERE ANKYLOSING SPONDYLITIS AND ITS CO-MORBIDITIES IN 2012 IN FRANCE: ANALYSIS OF A NATIONAL PUBLIC HEALTH INSURANCE DATABASEANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-011PREAI
REAL WORLD UTILIZATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS PATIENTS: A FRENCH NATIONAL CLAIMS DATABASE ANALYSIS OVER THE PERIOD 2009-2011VALUE IN HEALTHIF62013-11-011OAAI
MANAGEMENT OF FOCAL EPILEPSY TREATED BY POLYTHERAPY IN FRANCE: THE COST OF PHARMACO-RESISTANCEVALUE IN HEALTHIF62011-11-010OAAI
COST-MINIMIZATION ANALYSIS OF SECOND-LINE CHEMOTHERAPY FOR NON-SMALL-CELL LUNG CANCER (NSCLC)VALUE IN HEALTHIF62011-11-012PREAI
RESTOR® VERSUS ACRILISA® : ND-YAG LASER INCIDENCE RATE COMPARISON 18 MONTHS AFTER SURGERYVALUE IN HEALTHIF62009-10-010OAAI
VISION WITH RESTOR®, ARRAY® SA40 AND A MONOFOCAL INTRA-OCULAR LENS (IOL) AFTER CATARACT SURGERYVALUE IN HEALTHIF62008-11-010OAAI
COST-EFFECTIVENESS OF THREE INTRA-OCULAR LENSES AFTER CATARACT SURGERY IN THE NETHERLANDS: RESTOR®, ARRAY-SA40® AND A MONOFOCALVALUE IN HEALTHIF62008-11-010OAAI
RESTOR® VERSUS ACRILISA® ND-YAG LASER INCIDENCE RATE COMPARISON ONE YEAR AFTER SURGERYVALUE IN HEALTHIF62008-11-010OAAI